Ropivacaine Market

Ropivacaine is the first pure levorotatory long-term amide kinds of local anesthetics, like other local anesthetics, by blocking sodium ions into the nerve fibers within the cell membrane of the impulses along nerve fibres produce reversible block, has the dual effect of anesthesia and analgesia, large doses can produce a surgical anesthesia, occurs in small doses of sensory blockade (analgesic) only accompanied by limitations of progressive motor nerve block.The addition of epinephrine did not alter the block strength and duration of ropivacaine.

Ropivacaine Market contains market size and forecasts of Ropivacaine in global, including the following market information:

Global Ropivacaine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ropivacaine Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Ropivacaine companies in 2021 (%)

The global Ropivacaine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lumbar Epidural Administration Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ropivacaine include AstraZeneca, Aspen Pharmacare, Celgene, Taiwan Liposome Company, Nuvo Pharmaceuticals, Heron Therapeutics, Encore Therapeutics, PainReform Ltd and Anhui Wellman Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Ropivacaine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ropivacaine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Ropivacaine Market Segment Percentages, by Type, 2021 (%)

Lumbar Epidural Administration

Thoracic Epidural Administration

Regional Block

Global Ropivacaine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Ropivacaine Market Segment Percentages, by Application, 2021 (%)

Anesthesia

Systemic Neuropathic Pain

Postherpes Pain

Post-Operative Pain

Surgical Analgesia

Labor Analgesia

Other

Global Ropivacaine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Ropivacaine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ropivacaine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Ropivacaine revenues share in global market, 2021 (%)

Key companies Ropivacaine sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Ropivacaine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca

Aspen Pharmacare

Celgene

Taiwan Liposome Company

Nuvo Pharmaceuticals

Heron Therapeutics

Encore Therapeutics

PainReform Ltd

Anhui Wellman Pharmaceutical

Yichang Renfu Pharmaceutical

Shandong New Era Pharmaceutical

Shanxi Pude Pharmaceutical

Guangdong Huarun Shunfeng Pharmaceutical

Guangdong Jiabo Pharmaceutical

Chengdu Tiantaishan Pharmaceutical

Yangtze Pharmaceutical Group

Jiangsu Hengrui Pharmaceutical

Jiangsu Enhua Pharmaceutical

Hebei Yipin Pharmaceutical

Zhejiang Xianju Pharmaceutical

Hainan Sida Pharmaceutical

Xi'an Hanfeng Pharmaceutical

Chenxin Pharmaceutical

Shaanxi Bosen Biopharmaceutical

Qilu Pharmaceutical

Shenyang Sansheng Pharmaceutical